Dr. Chelsea Osterman joined ARPA-H as a Program Manager in November 2026. She is a medical oncologist who focuses on reimagining clinical trial design and delivery. Before joining ARPA-H, Osterman was an Executive Medical Director with Tempus AI, where she helped grow the TIME clinical trial network and led multiple superintelligence initiatives to improve trial efficiency. She previously practiced oncology in Asheville, NC, and worked in Real World Evidence at Flatiron Health.
Osterman completed her residency in internal medicine at the University of Pennsylvania and fellowship in oncology at the University of North Carolina.